Interestingly, recently IL-23 which expression is regularly upregulated in IBD tissues was suggested to be critically involved in driving alternative immune pathways specifically active in patients suffering from an anti-TNF-alpha blockade resistant disease (14). Here, IL23A is linked to inflammatory bowel disease.